Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH)Zacks Investment Research • 03/06/25
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue GuidanceGlobeNewsWire • 01/13/25
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024GlobeNewsWire • 11/06/24
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21GlobeNewsWire • 08/12/24
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue GuidanceGlobeNewsWire • 07/08/24
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer OfferingGlobeNewsWire • 03/12/24